-
-
-
-
-
-
-
MBX (MBX) Reports Q2 Loss of $0.78
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on MBX Biosciences Inc (MBX): "We remain buyers of MBX following 4Q25 earnings"
-
-
-
-
-
-
-
MBX Biosciences names Laurie Stelzer to board as audit chair
-
-
-
-
-
-
-
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
-
-
-
-
-
-
-
Microbix Assisting EMQN with Second Genetic-Test EQA Program
-
-
-
-
-
-
-
Microbix Exhibiting & Presenting at ADLM
-
-
-
-
-
-
-
Microbix Schedules Release of Results for Q2 Fiscal 2025
-
1,233,812 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


